| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Regencell (BVI) Ltd | 89% | +2.8% | $136,711,167,415 | +$133,207,714,899 | 437,896,116 | +3802% | Yat-Gai Au | 11 Jul 2025 |
As of 30 Sep 2025, 16 institutional investors reported holding 633,811 shares of Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC). This represents 0.13% of the company’s total 494,239,409 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 633,811 | $9,791,796 | -$392,658 | $15.45 | 16 |
| 2025 Q2 | 691,718 | $11,786,875 | +$10,844,557 | $17.04 | 14 |
| 2025 Q1 | 8,830 | $281,277 | +$62,573 | $31.88 | 5 |
| 2024 Q4 | 31,556 | $155,887 | +$66,403 | $4.94 | 3 |
| 2024 Q3 | 18,114 | $100,442 | +$97,348 | $5.55 | 2 |
| 2024 Q2 | 563 | $1,892 | -$3,655 | $3.36 | 3 |
| 2024 Q1 | 1,651 | $7,435 | -$65,939 | $4.50 | 3 |
| 2023 Q4 | 16,304 | $171,178 | +$167,367 | $10.50 | 3 |
| 2023 Q3 | 662 | $9,271 | +$1,725 | $14.00 | 4 |
| 2023 Q2 | 539 | $11,697 | -$4,939 | $21.70 | 2 |
| 2023 Q1 | 736 | $18,871 | -$11,954 | $25.88 | 4 |
| 2022 Q4 | 1,188 | $32,314 | -$223,077 | $27.20 | 3 |
| 2022 Q3 | 8,195 | $260,000 | -$9,603 | $31.69 | 5 |
| 2022 Q2 | 8,498 | $296,000 | -$146,386 | $34.60 | 5 |
| 2022 Q1 | 19,813 | $424,000 | +$196,066 | $21.41 | 3 |
| 2021 Q4 | 7,008 | $230,000 | -$86,001 | $32.06 | 2 |
| 2021 Q3 | 13,973 | $316,000 | +$316,001 | $22.63 | 3 |